DNA X, Inc.
SONM
$3.94
-$0.54-12.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 16.21M | 11.19M | 16.72M | 14.98M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 16.21M | 11.19M | 16.72M | 14.98M |
| Cost of Revenue | -- | 14.40M | 10.35M | 8.37M | -- |
| Gross Profit | -- | 1.82M | 845.00K | 8.36M | -- |
| SG&A Expenses | -12.96M | 5.62M | 6.67M | 6.08M | -13.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -48.79M | 20.19M | 17.92M | 16.08M | -51.75M |
| Operating Income | 4.66M | -3.98M | -6.73M | 645.00K | 8.44M |
| Income Before Tax | 3.45M | -4.66M | -7.34M | 590.00K | 8.87M |
| Income Tax Expenses | -- | 90.00K | 139.00K | 132.00K | -- |
| Earnings from Continuing Operations | 3.82M | -4.75M | -7.48M | 458.00K | 9.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.89M | -4.75M | -7.48M | 458.00K | -21.61M |
| EBIT | 4.66M | -3.98M | -6.73M | 645.00K | 8.44M |
| EBITDA | 6.16M | -3.03M | -5.94M | 1.70M | 9.35M |
| EPS Basic | -9.44 | -4.83 | -14.15 | 1.41 | -81.87 |
| Normalized Basic EPS | 4.76 | -2.96 | -7.97 | 1.14 | 21.52 |
| EPS Diluted | -9.44 | -4.83 | -14.22 | 1.41 | -81.87 |
| Normalized Diluted EPS | 4.76 | -2.96 | -7.97 | 1.13 | 21.52 |
| Average Basic Shares Outstanding | 722.70K | 984.90K | 528.40K | 324.40K | 262.10K |
| Average Diluted Shares Outstanding | 722.70K | 984.90K | 528.40K | 326.00K | 262.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |